Subodh Khamkar, General Manager - Technical

Ram Santosh, Head - Sales

The global containment solutions for pharmaceuticals industries market is flourishing with the growing demand for highly potent APIs as a primary catalyst. In addition to this sector, growing cancer cases, leading to greater demand and innovation of oncology drugs is also fueling the demand for sophisticated containment solutions, capable of handling the potent and potentially hazardous compounds involved in these disciplines. Consequently, significant investments into research and development of advanced containment solutions are being made, to meet the industry needs, as well as address regulatory requirements.

However, customers from the pharma and biotechnology sectors struggle with complexities like optimizing equipment selection for diverse operational needs, balancing cost with performance, and ensuring seamless integration with existing infrastructure. Adding fuel to the fire is the fact that the market is flooded with subpar, non-regulatory equipment which leads to frequent disruptions. To address these challenges, Isovax Technologies, a Mumbai-based, 2021 founded containment solutions provider has emerged as a beacon of hope, providing comprehensive solutions from identifying the right equipment to tailoring solutions as per the client’s business objectives and operations.

All-Encompassing Solutions

Adopting a consultative approach to understanding and fulfilling client needs, Isovax Technologies stands out as a provider of personalized containment solutions. The team of experts assists clients in identifying what the best containment equipment and overall solutions are for the specific applications for which the client requires them. Boasting a wide-ranging portfolio of solutions, encompassing everything from transportable units to advanced standalone systems, the company seamlessly caters to distinct budgetary limitations as well.

In addition to providing exceptional solutions in terms of equipment, the company also excels in installing and integrating the new systems within existing infrastructure without causing disruptions in operations. Through its relentless pursuit of excellence, the firm strives to exceed expectations, and drive a positive customer experience.

“Isovax isn't about selling containment solutions; it's about solving problems. We partner with pharmaceutical and chemical companies to understand their deepest pain points. Our focus is on building trust, not just transactions. We deliver on time, within budget, and without excuses. After the sale is when the real relationship starts. We are not just providing a product; we are offering a long-term advantage. If you're into anything that demands containment, we are a friend you must have”, shares Subodh Khamkar - Business Unit Head, Isovax Technologies.

The excellence of Isovax’s solutions is driven by its dedicated r&d team that tirelessly pursues innovations in containment technology. In collaboration with industry experts and top researchers, the team integrates advanced processes such as lyophilization, drying, compression, micronization, encapsulation, and granulation into its equipment. Central to the company’s innovative pursuits is aligning its systems and solutions with sustainability goals. As such, the team has designed containment solutions that are energy efficient and curated with reusable and durable materials.

But what gives the company its competitive edge is an amalgamation of differentiators including its comprehensive solutions, unparalleled customization capabilities, unwavering commitment to design excellence, and the vast vendor network it holds which facilitates the development of innovative solutions. The combined impact of these factors, and the financial stability and resources extended by its parent company HVAX Technologies has put Isovax in a formidable position.

Journey and Future Roadmap

Since its inception, only three short years ago, Isovax has achieved remarkable success and growth. The company has banked a humongous revenue milestone by hitting $2 million in this short span, demonstrating its strength and strategic prowess on a global platform. Beyond revenue growth, the company is also successfully expanding its geographical footprint and visibility within India and overseas, having penetrated four markets in this short period.

“We've experienced substantial growth in our market share, solidifying our presence in India and expanding our global footprint. Our unwavering commitment to innovation has led to the development of groundbreaking containment solutions that have set new industry standards. As a result of these achievements, Isovax has earned a stellar reputation for delivering high-quality containment equipment. As we look to the future, we plan to double our financial growth by the end of next year, leveraging the advantageous position our global reach has provided to capture new opportunities”, speaks Ram Santosh, Head of Sales.

With a favorable standing in the industry, and the immense scope the industry presents for growth, Isovax is poised to grow rapidly, conquering all opportunities to achieve its purpose of engineering tomorrow’s solutions, today. With this aspiration, the company has segmented its future strategies into three focal areas: building intelligent systems (isolators, robots, etc) that drive precision and efficiency; not merely meeting, but shaping industry standards, allowing clients to focus on their core business rather than becoming focused on the nitty gritties; and delving into the evolving principles of sustainability to develop containment solutions that are kind to the planet and suitable for the clients’ applications.

Dedicated to shaping a sustainable path for the industry, lowering footprint and increasing impact, Isovax is committed to becoming an industry pioneer, a revolutionary force that designs solutions which not only meet the bottom line, but exceed industry norms, quality standards, and client expectations in one single sweep.